Feasibility and psychometrics of an ambulatory hot flash monitoring device

Menopause

Volumn 6, Issue 3, 1999, Pages 209-215

  Carpenter, Janet S ^a,d   Andrykowski, Michael A ^b   Freedman, Robert R ^c   Munn, Rita ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

Ambulatory monitoring; Breast neoplasms; Hot flashes; Menopause; Skin conductance

Indexed keywords

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HOT FLUSH; HUMAN; MENOPAUSE; PSYCHOMETRY; QUALITY OF LIFE; SKIN CONDUCTANCE;

EID: 0032863529     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-199906030-00006     Document Type: Article

References (30)

1. Kronenberg F. Hot flashes: epidemiology and physiology. Ann NY Acad Sci 1990;592:52-86.
2. Kronenberg F. Hot flashes: phenomenology, quality of life, and search for treatment options. Exp Geront 1994;29:319-36.
3. Brzezinski A. Management of menopause in women with breast cancer. Isr J Med Sci 1995;31:163-8.
4. Cobleigh MA, Berris RF, Bush T, et al. Estrogen replacement in breast cancer survivors: a time for change. JAMA 1994;272:540-5.
5. Runowicz CD. Hormone replacement therapy in cancer survivors: a con opinion. CA Cancer J Clin 1996;46:365-73.
6. Smith HO, Kammerer-Doak DN, Barbo DM, Sarto GE. Hormone replacement therapy in the menopause: a pro opinion. CA Cancer J Clin 1996;46:343-63.
7. Wile AG, Opfell RW, Margileth DA. Hormone replacement therapy in previously treated breast cancer patients. Am J Surg 1993;165:372-5.
8. Anonymous. Consensus statement: Treatment of estrogen deficiency symptoms in women surviving breast cancer. J Clin Endocrinol Metab 1998;83:1993-2000.
9. Kessl B. Alternatives to estrogen for menopausal women. Proc Soc Exp Biol Med 1998;217:38-44.
10. Mayer DK, Linscott E. Information for women: management of menopausal symptoms. Oncol Nurs Forum 1995;22:1567-70.
11. Barton DL, Loprinzi CL, Quella SK, et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 1998;16:495-500.
12. Bergmans M, Merkus J, Corbey RS, Schellekens LA, Ubachs J. Effect of Bellergal retard on climacteric complaints: a double-blind, placebo-controlled study. Maturitas 1987;9:22-34.
13. Goldberg RM, Loprinzi CL, O'Fallon JR, et al. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol 1994;12:155-8.
14. Irvin JH, Domar AD, Clark C, Zuttermeister PC, Friedman R. The effects of relaxation response training on menopausal symptoms. J Psychosom Obstet Gynaecol 1996;17:202-7.
15. Loprinzi CL, Michalak JC, Quella SK, et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med 1994;33:347-52.
16. Loprinzi CL, Pisansky TM, Foneseca R, et al. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol 1998;16:2377-81.
17. Quella SK, Loprinzi CL, Sloan JA, et al. Long-term use of megestrol acetate by cancer survivors for the treatment of hot flashes. Cancer 1998;82:1784-8.
18. Stevenson DW, Delprato DJ. Multiple component self-control program for menopausal hot flashes. J Behav Ther Exp Psychiatry 1983;14:137-40.
19. Wijma K, Melin A, Nedstrand E, Hammar M. Treatment of menopausal symptoms with applied relaxation: a pilot study. J Behav Ther Exp Psychiatry 1997;28:251-61.
20. Tataryn IV, Lomax P, Meldrum DR, Bajorek JG, Chesarek W, Judd HL. Objective technique for the assessment of postmenopausal hot flashes. Obstet Gynecol 1981;57:340-4.
21. Freedman RR. Laboratory and ambulatory monitoring or menopausal hot flashes. Psychophysiology 1989;26:573-9.
22. Freedman RR, Norton D, Woodward S, Cornelissen G. Core body temperature and circadian rhythm of hot flashes in menopausal women. J Clin Endocrinol Metab 1995;80:2354-8.
23. Love RR. Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects. J Clin Oncol 1989;7:803-15.
24. Love RR, Cameron L, Connell BL, Levanthal H. Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med 1991;151:1842-7.
25. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-88.
26. Reichman BS, Green KB. Breast cancer in young women: effect of chemotherapy on ovarian function, fertility, and birth defects. J Natl Cancer Inst Monogr 1994;16:125-9.
27. Brambilla DJ, McKinlay SM, Johannes CB. Defining the perimenopause for application in epidemiologic investigations. Am J Epidemiol 1994;140:1091-5.
28. Lykken DT, Venables PH. Direct measurement of skin conductance: a proposal for standardization. Psychophysiology 1971;8:656-72.
29. Schneider R, Fowles D. A convenient, non-hydrating electrolyte medium for the measurement of electrodermal activity. Psychophysiology 1978;15:483-6.
30. Carpenter JS, Andrykowski MA, Studts JL, et al. Hot flashes in postmenopausal women treated for breast cancer: prevalence, severity, correlates, management, and relation to quality of life. Cancer 1998;82:1682-91.